Summary
The fluorescent acridine derivative, quinacrine, was found to accumulate in rat and mouse pancreatic islet cells storing insulin, glucagon, pancreatic polypeptide, or somatostatin. Following administration of large doses of tolbutamide via an oro-gastric tube, the intensity of quinacrine fluorescence of insulin cells was substantially reduced. Similarly, the pancreatic insulin content was lowered. In contrast, the fluorescence intensity of the glucagon, pancreatic polypeptide and somatostatin cells appeared unaffected. Basal plasma insulin levels in the mouse were slightly elevated following quinacrine administration (25%). Glucose-stimulated insulin release was markedly enhanced (51%) in quinacrine-pretreated animals, whereas insulin release induced by cholinergic stimulation was unaffected. The results show that quinacrine accumulates in the various pancreatic islet cells. The drug seems to be confined to the secretory granules and affects the insulin response to glucose but not that to cholinergic stimulation, suggesting that these secretagogues act through different or partly different secretory pathways.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ålund M, Olson L (1979) Quinacrine affinity of endocrine cell systems containing dense core vesicles as visualized by fluorescence microscopy. Cell Tiss Res 204: 171–186
Ekelund M, Ahrén B, Håkanson R, Lundquist I, Sundler F (1980) Quinacrine accumulates in certain peptide hormone-producing cells. Histochemistry 66: 1–9
Jennings BM (1965) Aldehyde-fuchsin staining applied to frozen sections for demonstrating pituitary and pancreatic beta-cells. J Histochem Cytochem 13: 328–333
Lundquist I, Hakanson R, Harris JB, Libelius R, Sundler F (1979) Endocrine pancreas in the dystrophic mouse. Ann NY Acad Sci 317: 206–220
Larsson L-I, Holst J, Håkanson R, Sundler F (1975) Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry 44: 281–290
Larsson L-I, Sundler F, Håkanson R (1976) Pancreatic polypeptide — a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia 12: 211–226
Alumets J, Sundler F, Håkanson R (1977) Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut. Cell Tissue Res 185: 465–479
Björklund A, Falck B, Owman Ch (1972) Fluorescence microscopic and microspectrofluorometric techniques for the cellular localization and characterization of biogenic amines. In: Berson SA (ed) Methods of investigative and diagnostic endocrinology, Vol 1. Rail JE, Kopin IJ (eds) The thyroid and biogenic amines. North-Holland Publication Company, Amsterdam, pp 318–368
Rerup C, Lundquist I (1966) Blood glucose level in mice I. Evaluation of a new technique of multiple serial sampling. Acta Endocrinol (Copenh) 52: 357–367
Ahrén B, Lundquist I (1981) Effects of selective and non-selective β-adrenergic agents on insulin secretion in vivo. Eur J Pharmacol 71: 93–104
Lundquist I (1972) Acid amyloglucosidase and carbohydrate regulation. I. Effect of exogenous amyloglucosidase on tissue glycogen, blood glucose and plasma insulin. Horm Metab Res 4: 151–158
Heding L (1966) A simplified insulin radioimmunoassay method. In: Donato L, Milhaud G, Sirchis J (eds) Labelled proteins in tracer studies. Euratom, Brussels, pp 345–350
Bruss ML, Black AL (1978) Enzymatic microdetermination of glycogen. Anal Biochem 84: 309–312
Dencker L, Lindquist NG, Tjälve H (1976) Uptake of 14C-labelled chloroquine and an 125I-labelled chloroquine analogue in some polypeptide hormone producing cell systems. Med Biol 54: 62–68
Tjälve H, Olsson S, Andersson A (1980) The uptake of 14C-chloroquine by mouse pancreatic islets in vitro. Acta Pharmacol Toxicol (Copenh) 47: 38–44
Andersson A, Olsson S, Tjälve H (1980) Chloroquine inhibits the insulin production of isolated pancreatic islets. Biochem Pharmacol 29: 1729–1735
Winkler H (1977) The biogenesis of adrenal chromaffin granules. Neuroscience 2: 657–683
Hutton JC (1982) The internal pH and membrane potential of the insulin-secretory granule. Biochem J 204: 171–178
DeDuve C, deBarsy T, Poole B, Trouet A, Tulkens P, van Hoof F (1974) Lysosomotropic agents. Biochem Pharmacol 23: 2495–2531
Ålund M (1980) Juxtaglomerular cell activity during hemorrhage and ischemia as revealed by quinacrine histofluorescence. Acta Physiol Scand 110: 113–121
Rollo IM (1980) Drugs used in the chemotherapy of malaria. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 1038–1060
Wibo M, Poole B (1974) Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J Cell Biol 63: 430–440
Filkins JP (1969) Effect of chloroquine on hepatic lysosomes. Fed Proc 28: 266 (Abstract)
Hart PD'A, Young MR (1979) The effects of inhibitors and enhancers of phagosome-lysosome fusion in cultured macrophages on the phagosome membranes of ingested yeasts. Exp Cell Res 118: 365–375
Lundquist I (1975) Carbohydrate content and regulation following injection of different glycogenolytic enzymes. Enzyme 20: 234–247
Lundquist I, Lövdahl R (1977) Pattern of islet lysosomal enzyme activities and insulin secretory response. Enzyme 22: 385–390
Lundquist I (1982) Cholinergic muscarinic effects on insulin release in mice. Pharmacology 25: 338–347
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lundquist, I., Ahrén, B., Håkanson, R. et al. Quinacrine accumulation in pancreatic islet cells of rat and mouse: relationship to functional activity and effects on basal and stimulated insulin secretion. Diabetologia 28, 161–166 (1985). https://doi.org/10.1007/BF00273865
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00273865